World

Russian court sets date for closed trial of scientist who developed hypersonic missile

May 25, 2023

Moscow [Russia], May 25: The first of three Russian scientists arrested during the development of a hypersonic missile will appear in court next week, according to the St Petersburg court website.
The trial on criminal charges against Russian scientist Anatoly Maslov, 76, will begin on June 1. According to TASS, at the time of his arrest on June 27, 2022, Mr. Maslov was the head of research activities of the Institute of Theory and Applied Mechanics (ITAM) of the Russian Academy of Sciences, Siberia branch.
Mr. Maslov was taken to the Lefortovo detention center in Moscow. TASS cited a source familiar with the matter, revealing that this scientist was suspected of sharing classified information related to hypersonic missile research . The Russian Federal Security Service is responsible for investigating the incident before taking it to court.
Mr. Maslov and two other associates, Valery Zvegintsev and Alexander Shiplyuk, Director of ITAM, were both arrested on charges of serious treason.
All three are experts in hypersonic engineering, a key area for the development of Russia's next-generation missiles.
According to the St Petersburg court, Mr. Maslov's trial was classified as "top secret" and was not disclosed to the media or the public. Maslov's detention period was extended to November 10.
Regarding the speculation that the three scientists were arrested for revealing state secrets to China, Kremlin spokesman Dmitry Peskov said on May 24 that Moscow has not found any evidence that the scientists did the work. jobs for China.
Source: ThanhNien Newspaper

More news

Clinicians at Fortis' S.L. Raheja Hospital Successfully Perform 1st Bone Marrow Transplant, Marking a Major Milestone in Advanced Cancer Care

Mumbai (Maharashtra) [India], October 20: S.L. Raheja Hospital, Mahim - A Fortis Associate, has achieved a milestone in its clinical journey with the successful completion of its first-ever Bone Marrow Transplant (BMT) at the COE for Haemato-Oncology. The landmark procedure was performed on a critically ill 61-year-old patient named Bijayentimala Devi from Manipur diagnosed with Multiple Myeloma, a complex form of blood cancer. The patient underwent an autologous stem cell transplant, which has led to a remarkable improvement in health, weight gain, and overall well-being -- bringing renewed hope to patients suffering from serious haematological conditions.

Oct 20, 2025